MedicalSystem Biotechnology Co Ltd
SZSE:300439
Intrinsic Value
MedicalSystem Biotechnology Co., Ltd. engages in the research, development and manufacturing of bio-tech pharmaceutical products. [ Read More ]
The intrinsic value of one
MedicalSystem Biotechnology Co Ltd
stock under the Base Case scenario is
12.83
CNY.
Compared to the current market price of 10.06 CNY,
MedicalSystem Biotechnology Co Ltd
is
Undervalued by 22%.
MedicalSystem Biotechnology Co Ltd's market capitalization is 3.9B CNY.
MedicalSystem Biotechnology Co Ltd stock price is 10.06 CNY.
MedicalSystem Biotechnology Co Ltd stock price (10.06 CNY) is 22% less than its Intrinsic Value (12.83 CNY).
MedicalSystem Biotechnology Co Ltd stock price (10.06 CNY) is 19% less than its DCF Value (12.37 CNY). Open DCF Valuation
MedicalSystem Biotechnology Co Ltd stock price (10.06 CNY) is 24% less than its Relative Value (13.3 CNY). Open Relative Valuation
MedicalSystem Biotechnology Co Ltd has upside potential of 139% compared to the average analyst price target.
Open Wall St Estimates
MedicalSystem Biotechnology Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 10%.
MedicalSystem Biotechnology Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 10%.
MedicalSystem Biotechnology Co Ltd has positive Operating Income for the last twelve months.
MedicalSystem Biotechnology Co Ltd's ROE (Return on Equity) has decreased in the last 3 years from 11% to 10%.
MedicalSystem Biotechnology Co Ltd has positive Net Income for the last twelve months.
MedicalSystem Biotechnology Co Ltd's ROIC (Return on Invested Capital) has increased in the last 3 years from 8% to 10%.
MedicalSystem Biotechnology Co Ltd has positive three-year average ROE (Return on Equity): 9%. The company is efficient at transforming stockholders' equity into net income.
MedicalSystem Biotechnology Co Ltd has positive three-year average ROIC (Return on Invested Capital): 9%. The company is efficient at using invested capital to generate operating income.
MedicalSystem Biotechnology Co Ltd's Revenue has been falling by 8% per year for the last 3 years.
MedicalSystem Biotechnology Co Ltd's Revenue has dropped by 22% over the past 12 months.
MedicalSystem Biotechnology Co Ltd has positive Free Cash Flow for the last twelve months.
MedicalSystem Biotechnology Co Ltd has positive Gross Profit for the last twelve months.
MedicalSystem Biotechnology Co Ltd's short-term assets (2B CNY) exceed its short-term liabilties (699m CNY).
MedicalSystem Biotechnology Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.03.
MedicalSystem Biotechnology Co Ltd's long-term assets (3B CNY) exceed its long-term liabilties (774m CNY).
MedicalSystem Biotechnology Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (958m CNY) than debt (89m CNY).
MedicalSystem Biotechnology Co Ltd's Altman Z-Score is very high and is equal to 4.25.
Valuation Backtest
MedicalSystem Biotechnology Co Ltd
Run backtest to discover the historical profit from buying and selling
MedicalSystem Biotechnology Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
This note will be permanently deleted.
MedicalSystem Biotechnology Co Ltd
Balance Sheet Decomposition
MedicalSystem Biotechnology Co Ltd
| Current Assets | 1.9B |
| Cash & Short-Term Investments | 958.3m |
| Receivables | 630.3m |
| Other Current Assets | 310.6m |
| Non-Current Assets | 1.6B |
| Long-Term Investments | 160.9m |
| PP&E | 1.2B |
| Intangibles | 127.8m |
| Other Non-Current Assets | 122.9m |
| Current Liabilities | 699.1m |
| Accounts Payable | 318.5m |
| Accrued Liabilities | 109.6m |
| Short-Term Debt | 65.1m |
| Other Current Liabilities | 206m |
| Non-Current Liabilities | 75.1m |
| Long-Term Debt | 23.6m |
| Other Non-Current Liabilities | 51.5m |
Earnings Waterfall
MedicalSystem Biotechnology Co Ltd
|
Revenue
|
1.9B
CNY
|
|
Cost of Revenue
|
-1B
CNY
|
|
Gross Profit
|
831.7m
CNY
|
|
Operating Expenses
|
-567.6m
CNY
|
|
Operating Income
|
264.1m
CNY
|
|
Other Expenses
|
128.7k
CNY
|
|
Net Income
|
264.2m
CNY
|
Free Cash Flow Analysis
MedicalSystem Biotechnology Co Ltd
| CNY | |
| Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
MedicalSystem Biotechnology Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Score
MedicalSystem Biotechnology Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
MedicalSystem Biotechnology Co Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
MedicalSystem Biotechnology Co Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
MedicalSystem Biotechnology Co Ltd
According to Wall Street analysts, the average 1-year price target for
MedicalSystem Biotechnology Co Ltd
is 24 CNY
.
Shareholder Return
Price
MedicalSystem Biotechnology Co Ltd
| Average Annual Return | -0.59% |
| Standard Deviation of Annual Returns | 33.21% |
| Max Drawdown | -73% |
| Market Capitalization | 3.9B CNY |
| Shares Outstanding | 383 950 016 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
MedicalSystem Biotechnology Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
MedicalSystem Biotechnology Co., Ltd. engages in the research, development and manufacturing of bio-tech pharmaceutical products. The company is headquartered in Ningbo, Zhejiang and currently employs 2,406 full-time employees. The company went IPO on 2015-04-22. The Company’s in-vitro diagnostic products include in-vitro diagnostic reagent and in-vitro diagnostic instrument. In addition, the Company is also involved in the provision of third-party medical diagnosis services, as well as the production and distribution of reagent raw materials. The firm mainly operates businesses in domestic market.
Contact
IPO
Employees
Officers
The intrinsic value of one
MedicalSystem Biotechnology Co Ltd
stock under the Base Case scenario is
12.83
CNY.
Compared to the current market price of 10.06 CNY,
MedicalSystem Biotechnology Co Ltd
is
Undervalued by 22%.
You don't have any saved screeners yet
